Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.19 -0.02 (-11.45%)
As of: Oct 22, 2026 · 1:20 PM EDT

Senti Biosciences Holdings (SNTI) Short term Debt (2026)

Updated

Senti Biosciences Holdings (SNTI) recorded Short term Debt of $3.99 million in Q2 2026.

Analysis

Senti Biosciences Holdings (SNTI) Short term Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.98 Bn 1,134.57 Bn 19.71 Bn
2 Johnson & Johnson 643.66 Bn 563.53 Bn 17.30 Bn
3 AbbVie 500.95 Bn 474.06 Bn 12.70 Bn
4 Merck 358.08 Bn 312.45 Bn 12.21 Bn
5 Novartis Ag 301.84 Bn 265.83 Bn 11.24 Bn
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn
7 Amgen 241.42 Bn 196.81 Bn 7.24 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn
10 Senti Biosciences Holdings 6.00 Mn -50.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.99 Mn
API Access

Senti Biosciences Holdings Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=SNTI&period=max&api_key=YOUR_API_KEY